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Acute effects of simultaneous intraperitoneal infusion of glu- eral metabolic problems have arisen [2–4]. In particular,
cose and amino acids. CPD may have contrasting effects on the nutritional
Background. The feasibility of simultaneously infusing glu- status of patients [4–8]. On the one hand, CPD allowscose and amino acid (AA)-based peritoneal dialysis solutions
for fewer dietary restrictions than hemodialysis and sup-was tested to determine whether peritoneal dialysis patients
plies an extra amount of calories by means of glucosecould achieve an adequate nonprotein calorie/nitrogen ratio
while preventing a marked increase in blood urea nitrogen absorbed with the peritoneal fluid. On the other hand,
(BUN), which is usually seen if the AAs are administered the loss of proteins and amino acids (AAs) [5], anorexia
without glucose. related to glucose loading and gastrointestinal distur-Methods. An automatic peritoneal dialysis cycler was used
bances, peritonitis, and possible low-grade inflammatoryto infuse glucose and AA solutions (3:1) simultaneously during
responses induced by particles and chemicals might causethe night. Eight infusions of 1000 mL m2 of body surface area
(BSA), with a 60 minute dwell time, were performed in 10 adverse consequences. Although these factors may en-
children on peritoneal dialysis. The dialytic effluent was ana- gender malnutrition in CPD patients, inadequate intake
lyzed at every exchange and totaled at eight hours to evaluate of proteins and calories appears to be an important cause.volume, glucose, and AA concentration. Blood samples for
Furthermore, serious plasma and muscle AA alterationsplasma, glucose, insulin, and free AA determination were
have been reported in patients on CPD [9–14].drawn at the beginning of automated peritoneal dialysis (APD)
session and at each instillation of peritoneal dialysate. Adequate protein and energy intakes are essential to
Results. The mean glucose absorption was 33.7 6 10.0% and the maintenance of nitrogen balance and prevention of
the AA absorption was 55.2 6 13.2% of the infused amount, malnutrition. While treatment with oral calorie and pro-and the ratio of nonprotein calorie (derived from glucose) to
tein supplements is efficacious, the anorexia associatednitrogen (derived from AA) was 115.4:1. The insulin levels
returned to normal only three hours after the beginning of with chronic renal failure frequently makes this thera-
APD. The free AA plasma levels were already increased two peutic approach very difficult to carry out. The use of
hours after dinner and remained high for the entire APD treat- AA-based dialysis fluid may provide opportunities for
ment because of the continuous absorption of AA from the
compensation of dialytic losses of protein and AA, sup-peritoneum. The BUN levels did not increase despite the sup-
plementation of inadequate dietary protein intake, andply of AA.
Conclusions. This APD procedure may improve utilization subsequent improvement in nutritional status, nitrogen
of AA for protein synthesis, as suggested by the lack of increase balance and plasma and muscle AA in CPD patients.
of the BUN levels with this regimen. Several investigators have examined the nutritional
benefit of substituting AA for glucose in peritoneal dial-
ysis solutions [15–23]. Some studies have reported a sig-
Chronic peritoneal dialysis (CPD) is widely used and nificant improvement in some nutritional parameters,
constitutes the dialytic therapy of choice in the manage- whereas others have shown no significant improvement
ment of end-stage renal failure (ESRF) in children [1]. in the same parameters.
Since the introduction of CPD into clinical practice, sev- In our experience, a simultaneous supply of calories
that is insufficient to allow the absorbed AA to be incor-
porated into new proteins, thus diverting their use forKey words: dialysate, automated peritoneal dialysis, nonprotein calo-
rie/nitrogen, hemodialysis adequacy, peritoneal dialysis. energy production, may have been the main cause of
failure [24]. Indeed, in almost all of the studies on theReceived for publication September 8, 1999
use of intraperitoneal AA, a significant increase in serumand in revised form November 14, 2000
Accepted for publication November 17, 2000 urea levels is reported, suggesting an unsatisfactory utili-
zation of the infused AA [11, 16, 20–23, 25–29]. More-Ó 2001 by the International Society of Nephrology
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Table 1. Patient characteristics
Body CPD PET creatinine PET glucose
Age Height weight BMI duration
Patient Diagnosis Sex years cm kg BMI percentile months D/P 2 h D/P 4 h D/P 2 h D/P 4 h
1 FGS M 13.2 140 36.9 18.8 50 6 0.41 0.63 0.62 0.43
2 FGS M 7.3 106.2 15.9 14.1 15–50 13 0.66 0.87 0.43 0.26
3 FGS M 7.2 112.7 19.3 15.2 50 29 0.68 0.95 0.51 0.22
4 RPGN M 7.1 122.5 20.7 13.8 15 4 0.48 0.69 0.53 0.36
5 KL M 16.5 166 59.3 21.5 50 16 0.34 0.68 0.74 0.42
6 RN M 9.0 121.2 21.8 14.8 15 7 0.42 0.64 0.58 0.4
7 RN M 5.5 94.2 12.6 14.2 15–50 48 0.52 0.85 0.46 0.21
8 RN F 8.2 114.4 20 15.3 15–50 4 0.42 0.59 0.54 0.37
9 RN F 11.9 150 36.9 16.4 15–50 4 0.38 0.5 0.61 0.41
10 FJNF F 11.1 132 25.4 14.6 ,5 4 0.36 0.5 0.6 0.43
Mean 9.7 125.9 26.9 15.9 36.0 13.5 0.47 0.69 0.56 0.35
SD 3.4 21.5 13.9 2.5 19.2 14.5 0.12 0.15 0.09 0.09
Abbreviations are: FGS, focal glomerulosclerosis; FJNF, familial juvenile nephronophtisis; RN, reflux nephropathy; KL, kidney lymphoma; RPGN, rapidly
progressive glomerulonephrites; BMI, body mass index [weight (kg)/height2 (m)]
over, it is well known that without an energy source, the study. None of the patients had any coexisting serious
illness, and all had normal liver function tests. The studynitrogen will not be effectively incorporated into pro-
teins; therefore, in parenteral nutrition, the combined was approved by the Ethics Committee of the G. Gaslini
Institute, and the informed consent was obtained by theinfusion of nonprotein calories and AA has been a key
factor in ensuring the best utilization of the AA. Total parents of the patients.
parenteral nutrition solutions with a nonprotein calorie
Dialysis solutions and APD schedulenitrogen ratio of 150:1 are appropriate for most patients.
The possibility of using peritoneal dialysis itself as a Two hours after a standard dinner containing 35% of
source of nutrients in the treatment of malnutrition is the daily calorie and protein intake, the children received
an intriguing concept. Unfortunately, it is not possible dialysis with an automated cycling machine (Home
to produce CPD bags, which contain both glucose and Choicet; Baxter Healthcare, McGraw Park, IL, USA).
AA because of such technical problems of preservation The prescribed dialysis solutions were one-quarter glu-
as crystallization and caramelization. Hence, the simulta- cose 3.86%, one-half glucose 2.27%, and one quarter
neous infusion of glucose and AA is not possible in contin- AA 1.1% (Nutrinealt PD4; Baxter Healthcare, Milan,
uous ambulatory peritoneal dialysis (CAPD). Conversely, Italy), thus making up a solution containing 0.275% of
automated peritoneal dialysis (APD), which is based on AA and 2.1% of glucose. The concentrations of the vari-
the use of cyclers, enables different types of solutions to ous constituents are shown in Table 3.
be infused simultaneously. This raises the question of To ascertain the thorough mixing of AA and glucose,
whether APD, using a combined intraperitoneal infusion we first tested the concentrations of glucose and AA in
of AA and glucose, is a valid means of providing an the solution leaving the mixing bag at each exchange
extra amount of readily available nitrogen and calories, (for eight exchanges) in all of the patients. The mean
and whether an adequate nonprotein calorie/nitrogen glucose concentration was 20.84 6 0.23 g/L, and the
ratio could prevent the marked increase in blood urea mean AA concentration was 0.271 6 0.005 g/L. The
nitrogen (BUN) usually seen if the AAs are administered coefficient of variation in the eight exchanges was 0.052
without glucose. for glucose and 0.054 for AA.
Bags were weighed before and after APD in order to
establish the exact amount of glucose and AA infused.
METHODS
Eight exchanges of 1000 mL m2 body surface area (BSA)
Subjects were performed with a dwell time of 60 minutes, an
infusion time of 10 minutes, and a drainage time of 5Ten metabolically stable children (seven males and
three females, aged 5.5 to 16.5 years) were studied. Perti- minutes. During the testing period, the patients were not
allowed any oral food intake.nent clinical data of the patients and data generated
from a standardized peritoneal equilibration test (PET) The amount of calories provided was calculated as
3.75 calories per gram of anhydrous glucose absorbed.according to Warady et al are reported in Table 1 [30].
The biochemical data are reported in Table 2. For the calculation of the grams of nitrogen contained
in the AA absorbed, it was assumed that 16% of theAll patients were well established on CPD and had
been free of peritonitis for at least two months before AA absorbed was nitrogen.
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Table 2. Serum biochemistry in 10 chronic peritoneal dialysis (CPD) children
Serum Blood urea Total Serum
Serum Serumcreatinine nitrogen protein albumin
Hemoglobin bicarbonate glucose
Patient mg/dL g/dL mmol/L g/L mg/dL
1 12.4 56.1 9 27.9 60 33 89
2 10.8 78.0 9.2 25 76 42 89
3 9.5 82.2 9.5 24.8 71 44 90
4 5.7 50.9 10.1 27 64 36 93
5 7.6 38.3 8.7 24.8 62 39 102
6 6.4 92.1 10.7 19.9 71 44 81
7 5.4 79.0 13.1 20.6 76 48 98
8 5.7 72.4 10.6 25.2 86 53 77
9 8.2 55.1 9.4 27.4 61 38 88
10 11.8 77.1 9.6 24.5 62 43 85
Mean 8.35 68.1 9.99 24.71 68.9 42 89.2
SD 2.6 16.9 1.3 2.6 8.6 5.8 7.4
Table 3. Composition of the dialysis solutions phy (HPLC) procedure for determining plasma and dial-
ysate free AA have been reported elsewhere [31, 32].1.1%
Amino 3.86% 2.27% Final
acids Glucose Glucose solution Statistical analysis
Na mmol/L 125 132 132 129.7 Statistical analysis was performed using the Student
Cl mmol/L 96 102 102 100
paired t test. Pearson’s coefficient of correlation (r) wasOsm mOsm/kg 365 480 390 411.7
pH 6.7 5.5 5.5 5.9 used to calculate the correlations. P , 0.05 was regarded
Ca mmol/L 1.25 1.75 1.75 1.58 as a significant difference.
Mg mmol/L 0.25 0.75 0.75 0.58
Lactate mmol/L 40 35 35 36.7
Amino acids g/L RESULTSSerine 0.509 0.127
Isoleucine 0.849 0.212 Automated peritoneal dialysis with a combined infu-
Leucine 1.019 0.255 sion of AA and glucose was well tolerated by all patients,Lysine 0.955 0.239
and no side effects were observed.Methionine 0.849 0.212
Phenylalanine 0.57 0.143 The amount of AA infused during the APD was 20.0 6
Threonine 0.645 0.161 4.0 g/m2 BSA, and the absorbed amount was 10.9 6 3.5Tryptophane 0.27 0.068
g/m2 BSA (55.2 1 13.2%). The amount of glucose infusedValine 1.393 0.348
Alanine 0.951 0.238 was 152.8 6 30.6 g/m2 BSA, of which 53.1 6 24.6 g/m2
Arginine 1.071 0.268 BSA was absorbed (33.7 6 10.0%). The percentage ofGlycine 0.509 0.127
absorption of AA and glucose gives a ratio of nonproteinHistidine 0.714 0.179
Proline 0.595 0.149 calories to nitrogen of 115.4:1.
Tyrosine 0.3 0.075 No significant correlation was found between the dialy-Glucose g/L 38.6 22.7 21
sate/plasma (D/P) ratio for creatinine and glucose at two
and four hours and the glucose and AA absorption dur-
ing the test. The mean ultrafiltration was 0.76 6 0.52
L/m2 BSA.Samples and assay methods
Table 4 reports the absorption in percentage and g/m2
Blood samples were collected before the start of APD BSA of glucose and AA at every exchange and the BUN,
and at the beginning of each instillation of peritoneal glucose, and insulin blood levels measured at every ex-
dialysate for analysis of urea, glucose, insulin, and change. The glucose and AA absorption did not show
plasma-free AA. The dialysate effluent was collected at significant differences in the eight exchanges ranging from
each exchange and the exact volume was recorded; the 30.9 6 11.8% to 35 6 14.8% of the infused amount for
dialysate was analyzed for urea, glucose and AA levels. glucose and from 49.6 6 13% to 55.1 6 17.3% for AA.
Urea and glucose were measured on a Beckman Syn- Blood urea nitrogen levels showed a slight but signifi-
chrom CX Autoanalyzer (Beckman Instruments, Fuller- cant decrease from the second (66 6 14 mg/dL) to the
ton, CA, USA). Insulin was measured by radioimmuno- eighth exchange (56.9 6 13.1 mg/dL).
assay (RIA)-coated tubes (Diagnostic Production Corp., Glucose plasma levels did not show significant differ-
Los Angeles, CA, USA). Methods for the plasma sample ences during the eight exchanges ranging from 85.1 6
32 mg/dL to 96.8 6 39.2 mg/dL.preparations and the high-pressure liquid chromatogra-
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The insulin plasma values that were higher than nor-
mal (22.8 6 9 IU/mL) at the start of APD, because of the
physiological postprandial increase, showed a significant
decrease to normal values after the fourth exchange
(15.4 6 9 IU/mL) and further declined from the fourth
to the eighth exchange.
Plasma AA levels during the study period are reported
in Table 5. Among the essential AAs, which were con-
tained in the 1.1% AA solution, histidine and isoleucine
concentrations did not show significant variations during
the eight exchanges. Leucine plasma concentrations were
reduced at the sixth exchange, and lysine plasma concen-
trations were significantly reduced only at the fifth ex-
change. Phenylalanine levels were significantly reduced
at the sixth and seventh exchange, and tyrosine levels
were significantly lower from the fourth to the eighth
exchange. Valine concentrations were significantly higher
from the first to the seventh exchange. Methionine levels
showed a significant rise from the first to the fourth
and at the seventh exchange, and threonine levels were
significantly raised only at the second exchange.
Among the nonessential AA, those contained in the
1.1% AA solution, namely arginine, glycine, serine, and
alanine, did not show significant variations in plasma
concentrations during the eight exchanges, except for a
significant decrease of glycine plasma levels at the first
exchange. Among the nonessential AA not contained
in the 1.1% AA solution, asparagine levels showed a
significant decrease from the first to the eighth exchange.
Glutamine levels were significantly reduced at the sec-
ond and from the fifth to the eighth exchange. Ornithine
concentrations were significantly lower from the fifth to
the seventh exchange. Citrulline plasma concentrations
were significantly higher from the first to the eighth ex-
change, and aspartic and glutamic acid showed a signifi-
cant rise, respectively, at the fourth and at the eighth
exchange.
DISCUSSION
The results of this study indicate that the simultaneous
infusion of glucose and AA into peritoneum is safe and
does not induce side effects. This finding corroborates
reports by Honda et al, who evaluated the acute effects
of the short-term use of a mixed solution of glucose and
essential AA in children on CAPD [33].
The absence of a significant correlation between the
D/P ratio for creatinine and glucose at two and four
hours and the glucose and AA absorption during the
test should be explained, at least in part, by the shorter
dwell time of the exchanges performed during the APD
treatment (60 minutes).
Both insulin and AA are necessary for the stimulation
of protein anabolism [34, 35]. Net protein depositionT
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Table 5. Plasma free amino acid levels (mmol/L) at start of APD and at every exchange
Exchange
0 1 2 3 4 5 6 7 8
Essential amino acids
Histidine 77628 80629 81626 73626 78625 70622 70629 68628 74624
Isoleucine 76623 81625 85624 78631 82628 73619 72615 70615 75620
Leucine 107629 108638 111634 103646 108639 94624 92624a 91627 96625
Lysine 198693 2086104 175668 169688 1696115 162677a 160690 170685 172667
Methionine 4368 50612a 55613b 52611a 57612b 54610 54610 5368b 54613
Phenylalanine 64617 67615 69620 63611 66615 63617 55612a 55613a 54613
Threonine 129638 138652 146651a 136642 151643 134630 140637 134628 138623
Tyrosine 51612 51614 49611 49617 45614b 3968b 37611b 37610b 3969a
Valine 172638 207647a 231650b 225651b 242657b 228641c 237640b 233642b 243637
Nonessential amino acids
Arginine 94637 102679 94639 83642 99668 101660 96666 109684 106665
Asparagine 76621 65620a 61615b 50613b 50615b 4367b 41610b 39610b 38611b
Aspartic acid 762 763 762 663 13613a 12612 11613 10611 10611
Citrulline 70629 78636a 81634b 86642a 96650a 85636b 87640b 82632b 81634b
Glutamic acid 74626 77623 78631 76629 94662 83648 93650 90657 100648a
Glutamine 6936184 6556180a 6476136 6156181 6136212 6016159b 5856159b 5906182a 6086174a
Glycine 259678 249681a 250659 237659 256681 252650 258668 252667 254663
Ornithine 58616 58623 60617 56622 59625 47618b 45621a 46620a 51618
Serine 102625 100632 98629 90621b 101634 93621 95627 91628 90624
Taurine 1 Alanine 4116101 3986106 387692 364686 397695 388681 376661 362666 360697
Total 27026398 27206578 27066377 26046494 27106623 26126309 25956429 25716465 26356393
EAA 9166182 9916244 10016195 9496248 9996270 9176132 9176177 9116150 9476113
NEAA 17866297 17296317 17056398 16556249 17126390 16946210 16776272 16606326 16876302
BCAA 355685 3966101a 4276100b 4076122a 4326119b 395678 400673a 394677 415674
Values are given as mean 6 SD. Histidine and tyrosine are regarded as EAA.
a P , 0.05, b P , 0.01, c P , 0.001 vs. 0
endogenous protein degradation, by the stimulation of the supply of selected AAs (valine, leucine, isoleucine,
and tyrosine) and potassium to muscle. The final effectprotein synthesis, or by both. A number of in vitro studies
have demonstrated that insulin inhibits protein degrada- on muscle protein balance may vary depending on which
of these two opposing factors—insulin versus reducedtion in the liver [36] and muscle [37]. Moreover, while
it stimulates protein synthesis in muscle [38], it does not substrate availability—predominates (abstract; Gari-
botto et al, J Am Soc Nephrol 9:282A, 1998).seem to have any such effect in the liver [36]. In addition,
AAs have been shown to stimulate protein synthesis In our study, both stimulatory effects were present.
The insulin levels were already high at the beginning ofdirectly in muscle [39] and suppress proteolysis in per-
fused rat liver [40]. Thus, both insulin and AA can di- APD because of the postprandial increase and returned
to normal only three hours after the beginning of APD.rectly stimulate protein anabolism in vitro. A number
of in vivo studies show that hyperinsulinemia decreases The free AA plasma levels were also already increased
two hours after dinner and remained high for the entireproteolysis and oxidation of essential AA [41–43].
Leucine kinetic data reveal that hyperinsulinemia and APD treatment because of the continuous absorption of
AA from the peritoneum. On account of the specifichyperaminoacidemia stimulate net protein anabolism by
different mechanisms. Hyperinsulinemia decreases pro- composition of the AA solution, the plasma levels of
selected AA with a key role in muscle protein synthesis,teolysis but does not stimulate leucine incorporation into
proteins, while hyperaminoacidemia per se stimulated namely valine, leucine, isoleucine, and tyrosine, showed
persistently high levels during the study period. Nothe incorporation of leucine in proteins but did not sup-
press endogenous proteolysis. When combined, they marked increases in arginine levels, which can result in an
excessive production of nitrogen oxide, were observed.have a cumulative effect on leucine deposition into body
proteins [44]. Several investigators have examined the nutritional
benefit of substituting AAs for glucose in peritoneal dial-A recent preliminary report indicates that peritoneal
dialysis causes concurrent acute anabolic and catabolic ysis solutions [15–23, 25–28, 33, 45, 46]. These studies
vary in length and in the AA formulation used; in someeffects on muscle protein dynamics. The glucose-induced
increase in insulin levels is followed by an inhibition studies, the patients selected were not malnourished,
and in general, these studies were conducted on a smallof muscle protein degradation. However, this anabolic
effect is blunted by a decrease in muscle protein synthe- number of patients. This may account to some extent
for the diversity in the results.sis, which is probably the consequence of a decrease in
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